加强监测,明确疫情
我国自1950年始,已把HFRS作为B类(相当于传染病法的乙类报告传染病)报告,历次对传染病法的修订,仍然把HFRS列为乙类法定报告传染病,可见国家对HFRS流行及其疫情的重视。
HFRS的流行,与鼠密度及带毒率有密切关系;此外HFRS的流行受自然因素与社会因素的影响密切相关,应加强监测、探索疫源地和疫区类型及其演变规律,分析疫情动态和发展趋势。总之,应明确疫区,才能对疫情进行准确地预测预报,进一步提高防治效果,虽然几十年的调查研究认为该病的流行存在周期性的变化,但目前年度疫情报告本病水平与2007年相近,在有疫苗可控的情况下,这种状况只能提示有明显的异常情况发生。
此外,应加强国境生物安全检查,严防在美洲国家流行的HCPS储存宿主流入我国。
(梁小洁 严延生)
参考文献
[1]Casals J,Henderson BE,Hoogstraal H,et al.A review of Soviet viral hemorrhagic fevers,1969[J].J Infect Dis,1970,122 (5) :437-453.DOI:10.1093/infdis/122.5.437.
[2]French GR,Foulke RS,Brand OA,et al.Korean hemorrhagic fever:propagation of the etiologic agent in a cell line of human origin[J].Science ,1981,211(4486):1046-1048.DOI:10.1126/science.6110243.
[3]Karabatsos N.International catalogue of arboviruses,including certain other viruses of vertebrates[J].Texas:American Society of Tropical Medicine and Hygiene,1985,445-451.
[4]King AMQ,Lefkowitz E,Mushegian AR,et al.Changes to taxonomy and the international code of virus classification and nomenclature ratified by the international committee on taxonomy of viruses (2018)[J].Arch Virol,2018,163(9):2601-2631.DOI:10.1007/s00705-018-3847-1.
[5]Aai S,Yanagihara R.Genetic diversity and geographic distribution of bat-borne hantaviruses[J].Curr Issues Mol Biol,2020,39:1–28.DOI:10.21775/cimb.039.001.
[6]张永振,肖东楼,王玉,等.中国肾综合征出血热流行趋势及其防制对策[J].中华流行病学杂志,2004,25(6):466-469.DOI:10.3760/j.issn:0254-6450.2004.06.002.
[7]Zhang Y,Zou Y,Fu ZF,et al.Hantavirus infections in humans and animals,China[J].Emerg Infect Dis,2010,16(8):1195-1203.DOI:10.3201/eid1608.090470.
[8]Lee HW,Lee PW,Johnson KM.Isolation of the etiologic agent of Korean hemorrhagic fever[J].J Infect Dis,1978,137:298–308.
[9]Lee HW,Baek LJ,Johnson KM.Isolation of Hantaan virus,the etiologic agent of Korean hemorrhagic fever,from wild urban rats[J].J Infect Dis,1982,146:638–644.
[10]Brummer-Korvenkontio M,Vaheri A,Hovi T,et al.Nephropathia epidemica:detection of antigen in bank voles and serologic diagnosis of humaninfection[J].J Infect Dis 1980,141:131–134.
[11]Niklasson B,Le Duc J.Isolation of the nephropathia epidemica agent inSweden[J].Lancet,1984,1:1012–1013.
[12]Kruger DH,Ulrich RG,Hofmann J.Hantaviruses as zoonotic pathogens in Germany[J].Dtsch Arztebl Int,2013,110 (27/28):461-467.DOI:10.3238/arztebl.2013.0461.
[13]Heyman P,Thoma BR,Marié JL,et al.In search for factors that drive hantavirus epidemics[J].Front Physiol,2012,3:237.DOI:10.3389/fphys.2012.00237.
[14]Latus J,Tenner-Racz K,Racz P,et al.Detection of puumala hantavirus antigen in human intestine during acute hantavirus infection[J].PLoS One,2014,9(5):e98397.DOI:10.1371/journal.pone.0098397.
[15]李立明,曹务春,段广才,等.流行病学[M].3版.北京:人民卫生出版社,2015.
[16]Hepojoki J,Strandin T,Lankinen H,et al.Hantavirus structuremolecular interactions behind the scene[J].J Gen Virol,2012,93(8):1631-1644.DOI:10.1099/vir.0.042218-0.(https://www.daowen.com)
[17]Zupanc TA,Saksida A,Korva M.Hantavirus infections[J].Clin Microbiol Infect,2019,21S:e6-e16.DOI:10.1111/1469-0691.12291.
[18] Zhang S,Wang S,Yin W,et al.Epidemic characteristics of hemorrhagic fever with renal syndrome in China,2006–2012[J].BMC Infect Dis,2014,14:384.DOI:10.1186/1471-2334-14-384.
[19]卫生部.卫生部关于印发《扩大国家免疫规划实施方案》的通知(卫疾控发〔2007〕305号)[EB/OL].(2007-12-29)[2018-05-02].http://www.nhc.gov.cn/bgt/pw 10803/200805/06e538cad856458bba92730b81e0f29c.shtml.
[20]Bai1 X,Peng C,Jiang T,et al.Distribution of geographical scale,data aggregation unit and period in the correlation analysis between temperature and incidence of HFRS in mainland China:A systematic review of 27 ecological studies[J].PLoS Negl Trop Dis,2019,13(8):e0007688.DOI:10.1371/journal.pntd.0007688.
[21]Enría D,Padula P,Segura EL,et al.Hantavirus pulmonary syndrome in Argentina.Possibility of person to person transmission[J].Medicina,1996,56(6):709-711.
[22]Wells RM,Sosa Estani S,Yadon ZE,et al.An unusual hantavirus outbreak in southern Argentina:person-to-person transmission Hantavirus pulmonary syndrome study group for Patagonia[J].Emerg Infect Dis,1997,3(2):171-174.DOI:10.3201/eid0302.970210.
[23]Gavrilovskaya IN,Peresleni T,Geimonen E,et al.Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration[J].Arch Virol ,2002,147(10):1913-1931.DOI:10.1007/s00705-002-0852-0.
[24]Schmaljohn C.The Bunyaviridae:Molecular biology of hantaviruses[M].New York:Plenum Press,1996,63-90.DOI:10.1007/978-1-4899-1364-7_3.
[25]Mackow ER,Gavrilovskaya IN.Cellular receptors and hantavirus pathogenesis[J].Curr Topics Microbiol Immunol,2001,256:91-115.DOI:10.1007/978-3-642-56753-7_6.
[26]Tuuminen,Kekalainen T,Makela E,et al.Human CD8+ T cell memory generation in puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBVspecific CD8+ memory T cells[J].J Immunol ,2007,179(3):1988-1995.DOI:10.4049/jimmunol.179.3.1988.
[27]Huang C,Jin B,Wang M,et al.Hemorrhagic fever with renal syndrome:relationship between pathogenesis and cellular immunity[J].J Infect Dis,1994,169(4):868-870.DOI:10.1093/infdis/169.4.868.
[28]Bi ZQ,Formenty PB,Roth CE.Hantavirus infection:a review and global update[J].J Infect Develop Countries ,2008,2(1):3-23.DOI:10.3855/jidc.317.
[29]Kruger DH,Ulrich R,Lundkvist AA.Hantavirus infections and their prevention[J].Microbes Infect,2001,3(13):1129-1144.DOI:10.1016/s1286-4579(01)01474-5.
[30]Kallio-Kokko H,Vapalahti O,Lundkvist A,et al.Evaluation of Puumala virus IgG and IgM enzyme immunoassays based on recombinant baculovirus-expressed nucleocapsid protein for early nephropathia epidemica diagnosis[J].Clin Diagnostic Virol ,1998,10(1):83-90.DOI:10.1016/S0928-0197(97)10019-8.
[31]Jonsson CB,Hooper J,Mertz G.Treatment of hantavirus pulmonary syndrome[J].Antiviral Res,2008,78(1):162-169.DOI:10.1016/j.antiviral.2007.10.012.
[32]Linderholm M,Elgh F.Clinical characteristics of hantavirus infections on the Eurasian continent[J].Curr Topics Microbiol Immunol,2001,256:135-151.DOI:10.1007/978-3-642-56753-7_8.
[33]Huggins JW.Prospects for treatment of viral hemorrhagic fevers with ribavirin,a broad-spectrum antiviral drug[J].RevI Infect Dis,1989,11(Suppl.4):S750-S761.
[34]Huggins JW,Hsiang CM,Cosgriff TM,et al.Prospective,double-blind,concurrent,placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome[J].J Infect Dis,1991,164(6):1119-1127.
[35]Rusnak JM,Byrne WR,Chung KN,et al.Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea[J].Antiviral Res ,2009,81(1):68-76.DOI:10.1016/j.antiviral.2008.09.007.
[36]王玉林,罗兆庄.中国肾综合征出血热疫苗的研究[J].中国媒介生物学及控制杂志,2003,14(5):398-399.DOI:10.3969/j.issn.1003-4692.2003.05.033.
[37] Ke G,Hu Y,Huang X,et al.Epidemiological analysis of hemorrhagic fever with renal syndrome in China with the seasonal-trend decomposition method and the exponential smoothing model[J].Sci Rep.2016.15;6:39350.DOI :10.1038/srep39350.